{
    "organizations": [],
    "uuid": "72fd1c776c9965146ebf4e32a75e66a57957483e",
    "author": "",
    "url": "https://www.reuters.com/article/brief-menlo-therapeutics-reports-qtrly-l/brief-menlo-therapeutics-reports-qtrly-loss-per-share-0-72-idUSASC0A13Z",
    "ord_in_thread": 0,
    "title": "BRIEF-Menlo Therapeutics Reports Qtrly Loss Per Share $0.72",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Updated 10 minutes ago BRIEF-Menlo Therapeutics Reports Qtrly Loss Per Share $0.72 Menlo Therapeutics Inc:\n* MENLO THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS * QTRLY LOSS PER SHARE $0.72\n* LOWERING ITS OPERATING EXPENSE GUIDANCE FOR FULL YEAR 2018 TO A RANGE OF APPROXIMATELY $68.0 MILLION TO $78.0 MILLION ",
    "published": "2018-05-09T23:16:00.000+03:00",
    "crawled": "2018-05-09T23:30:44.042+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "report",
        "qtrly",
        "loss",
        "per",
        "share",
        "menlo",
        "therapeutic",
        "inc",
        "menlo",
        "therapeutic",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "qtrly",
        "loss",
        "per",
        "share",
        "lowering",
        "operating",
        "expense",
        "guidance",
        "full",
        "year",
        "range",
        "approximately",
        "million",
        "million"
    ]
}